AMPH (Amphastar Pharmaceuticals) Cyclically Adjusted Book per Share: $11.93 (As of Mar. 2026)


AMPH Amphastar Pharmaceuticals Inc AMPH
83 GF Score
Price $21.78
GF Value $48.79
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Amphastar Pharmaceuticals Cyclically Adjusted Book per Share?

Amphastar Pharmaceuticals AMPH +3.52% 83 Cyclically Adjusted Book per Share is $11.93 as of Mar. 2026. GuruFocus rates AMPH with a GF Score™ of 83/100 and a GF Value™ of $48.79 (Significantly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Amphastar Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2026 was $17.326. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $11.93 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Amphastar Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 10.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Amphastar Pharmaceuticals was 9.10% per year. The lowest was 9.10% per year. And the median was 9.10% per year.

As of today (2026-06-27), Amphastar Pharmaceuticals's current stock price is $21.78. Amphastar Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $11.93. Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 1.83.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Amphastar Pharmaceuticals was 6.79. The lowest was 1.41. And the median was 3.63.


Amphastar Pharmaceuticals  (NAS:AMPH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=21.78/11.93
=1.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Amphastar Pharmaceuticals was 6.79. The lowest was 1.41. And the median was 3.63.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Amphastar Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


Amphastar Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Amphastar Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amphastar Pharmaceuticals Cyclically Adjusted Book per Share Chart

Amphastar Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 8.86 9.51 10.43 11.51

Amphastar Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.76 11.04 11.32 11.51 11.93

AMPH vs ETON, ESPR, BIOA: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amphastar Pharmaceuticals Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Amphastar Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


AMPH
83GF Score
Amphastar Pharmaceuticals Inc AMPH
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amphastar Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Amphastar Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=17.326/330.2130*330.2130
=17.326

Current CPI (Mar. 2026) = 330.2130.

Amphastar Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201606 6.819 241.018 9.343
201609 7.134 241.428 9.758
201612 7.119 241.432 9.737
201703 7.084 243.801 9.595
201706 7.207 244.955 9.715
201709 7.204 246.819 9.638
201712 7.158 246.524 9.588
201803 7.011 249.554 9.277
201806 6.905 251.989 9.048
201809 6.920 252.439 9.052
201812 7.129 251.233 9.370
201903 7.112 254.202 9.239
201906 8.214 256.143 10.589
201909 8.250 256.759 10.610
201912 8.188 256.974 10.522
202003 8.153 258.115 10.430
202006 8.373 257.797 10.725
202009 8.525 260.280 10.816
202012 8.470 260.474 10.738
202103 8.499 264.877 10.595
202106 8.794 271.696 10.688
202109 8.965 274.310 10.792
202112 9.337 278.802 11.059
202203 9.836 287.504 11.297
202206 10.192 296.311 11.358
202209 10.392 296.808 11.562
202212 10.988 296.797 12.225
202303 11.386 301.836 12.456
202306 12.070 305.109 13.063
202309 12.425 307.789 13.330
202312 13.302 306.746 14.320
202403 13.766 312.332 14.554
202406 14.569 314.175 15.313
202409 15.043 315.301 15.754
202412 15.379 315.605 16.091
202503 15.760 319.799 16.273
202506 16.293 322.561 16.680
202509 16.759 324.800 17.038
202512 17.281 324.054 17.609
202603 17.326 330.213 17.326

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $11.93 mean?
Amphastar Pharmaceuticals (AMPH) has a Cyclically Adjusted Book per Share of $11.93 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Amphastar Pharmaceuticals and its competitors.
Is Amphastar Pharmaceuticals' Cyclically Adjusted Book per Share too high?
Amphastar Pharmaceuticals' current Cyclically Adjusted Book per Share is $11.93. Overall, Amphastar Pharmaceuticals has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Amphastar Pharmaceuticals' Cyclically Adjusted Book per Share compare to ETON and ESPR?
Amphastar Pharmaceuticals' Cyclically Adjusted Book per Share of $11.93 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Amphastar Pharmaceuticals and its competitors. Amphastar Pharmaceuticals's current Cyclically Adjusted Book per Share is $11.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amphastar Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Amphastar Pharmaceuticals (AMPH) is currently considered Significantly Undervalued. The stock's GF Value™ is $48.79, compared to a current price of $21.78 — trading 55.4% below its estimated fair value. The current Cyclically Adjusted Book per Share is $11.93. Amphastar Pharmaceuticals' overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Amphastar Pharmaceuticals (AMPH), the current Cyclically Adjusted Book per Share is $11.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Amphastar Pharmaceuticals (AMPH) Overvalued in 2026?

Based on GuruFocus' analysis, Amphastar Pharmaceuticals stock appears to be undervalued. The current stock price of $21.78 is trading 55.4% below its estimated GF Value™ of $48.79. GuruFocus considers Amphastar Pharmaceuticals to be Significantly Undervalued.

Key valuation signals for AMPH:

  • Cyclically Adjusted Book per Share: $11.93
  • GF Value™: $48.79 vs. price of $21.78 (55.4% below fair value)
  • GF Score™: 83/100 with 6 warning signs

No single metric tells the full story. See the AMPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Amphastar Pharmaceuticals Business Description

Other Exchanges 29A:Germany
Address 11570 6th Street, Rancho Cucamonga, CA, USA, 91730
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
83GF Score

Get the complete analysis for AMPH

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.78
Price
$48.79
GF Value